1. Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma 
Mark Pines, David Snyder, Shai Yarkoni, Arnon Nagler 
Biology of Blood and Marrow Transplantation 
Volume 9, Issue 7, Pages (July 2003)
DOI: /S (03)

2. Figure 1
Collagen α1(I) gene expression. Skin biopsies were taken from the posterior upper back of the cGvHD patient before (A) and 6 months after (B) topical halofuginone therapy. The sections were hybridized with digoxigenin-labeled collagen α1(I) probe. Note the reduction in cells expressing the collagen α1(I) gene (arrows).
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )